Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP

Activation of phosphatidylinositol 3-kinase (PI3K) and activation of the 70/85-kDa S6 protein kinases (alpha II and alpha I isoforms, referred to collectively as pp70S6k) have been independently linked to the regulation of cell proliferation. We demonstrate that these kinases lie on the same signalling pathway and that PI3K mediates the activation of pp70 by the cytokine interleukin-2 (IL-2). We also show that the activation of pp70S6k can be blocked at different points along the signalling pathway by using specific inhibitors of T-cell proliferation. Inhibition of PI3K activity with structurally unrelated but highly specific PI3K inhibitors (wortmannin or LY294002) results in inhibition of IL-2-dependent but not phorbol ester (conventional protein kinase C [cPKC])-dependent pp70S6k activation. The T-cell immunosuppressant rapamycin potently antagonizes IL-2-(PI3K)- and phorbol ester (cPKC)-mediated activation of pp70S6k. Thus, wortmannin and rapamycin antagonize IL-2-mediated activation of pp70S6k at distinct points along the PI3K-regulated signalling pathway, or rapamycin antagonizes another pathway required for pp70S6k activity. Agents that raise the concentration of intracellular cyclic AMP (cAMP) and activate cAMP-dependent protein kinase (PKA) also inhibit IL-2-dependent activation of pp70S6k. In this case, inhibition appears to occur at least two points in this signalling path. Like rapamycin, PKA appears to act downstream of cPKC-mediated pp70S6k activation, and like wortmannin, PKA antagonizes IL-2-dependent activation of PI3K. The results with rapamycin and wortmannin are of added interest since the yeast and mammalian rapamycin targets resemble PI3K in the catalytic domain.

[1]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[2]  R. Abraham,et al.  Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[3]  N. Ruderman,et al.  The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. , 1994, The Journal of biological chemistry.

[4]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[5]  Andrius Kazlauskas,et al.  PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase , 1994, Nature.

[6]  J. Blenis,et al.  Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation , 1994, Molecular and cellular biology.

[7]  G. V. Vande Woude,et al.  Protein kinase A acts at multiple points to inhibit Xenopus oocyte maturation , 1994, Molecular and cellular biology.

[8]  A. Wittinghofer,et al.  Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides , 1994, Molecular and cellular biology.

[9]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[10]  R. Abraham,et al.  The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line , 1994, The Journal of experimental medicine.

[11]  L. Cantley,et al.  Lipid second messengers , 2017 .

[12]  A. Fernández,et al.  Nuclear localization of p85s6k: functional requirement for entry into S phase. , 1994, The EMBO journal.

[13]  E. Van Obberghen,et al.  Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. , 1994, The Journal of biological chemistry.

[14]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[15]  C. Marshall,et al.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.

[16]  J. Blenis,et al.  Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma. , 1994, Journal of immunology.

[17]  J. Kunz,et al.  TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. , 1994, Molecular biology of the cell.

[18]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[19]  Y. Nonomura,et al.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. , 1993, The Journal of biological chemistry.

[20]  A. Arcaro,et al.  Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.

[21]  J. Blenis,et al.  Activation of MAP kinases, pp90rsk and pp70‐S6 kinases in mouse mast cells by signaling through the c‐kit receptor tyrosine kinase or FcϵRI: rapamycin inhibits activation of pp70‐S6 kinase and proliferation in mouse mast cells , 1993, European journal of immunology.

[22]  S. Cook,et al.  Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.

[23]  P. Dent,et al.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. , 1993, Science.

[24]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Lawrence,et al.  Increasing cAMP attenuates activation of mitogen-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Bos,et al.  cAMP antagonizes p21ras‐directed activation of extracellular signal‐regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. , 1993, The EMBO journal.

[27]  M. Mclaughlin,et al.  Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity , 1993, Molecular and cellular biology.

[28]  D. Cantrell,et al.  Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor. , 1993, Seminars in immunology.

[29]  J C Reed,et al.  Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cells. , 1993, The Journal of biological chemistry.

[30]  Y. Ebina,et al.  Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. , 1993, Biochemical and biophysical research communications.

[31]  M. Diaz-Meco,et al.  Protein kinase C ζ isoform is critical for mitogenic signal transduction , 1993, Cell.

[32]  M. Siegmann,et al.  The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites. , 1993, The Journal of biological chemistry.

[33]  C. Crews,et al.  Extracellular signals and reversible protein phosphorylation: What to Mek of it all , 1993, Cell.

[34]  R. Davis,et al.  The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.

[35]  J. Blenis,et al.  Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Lane,et al.  p70s6k function is essential for G1 progression , 1993, Nature.

[37]  J. Kunz,et al.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.

[38]  L. Feig The many roads that lead to Ras. , 1993, Science.

[39]  A. Nel,et al.  Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. , 1993, Immunology.

[40]  T. Taniguchi,et al.  The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[41]  K. Takegawa,et al.  Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. , 1993, Science.

[42]  R. Denell,et al.  Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth , 1993, Molecular and cellular biology.

[43]  W. Greene,et al.  The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. , 1993, The Journal of biological chemistry.

[44]  Susan S. Taylor,et al.  A template for the protein kinase family. , 1993, Trends in biochemical sciences.

[45]  L. Cantley,et al.  A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity , 1993, Molecular and cellular biology.

[46]  J. Blenis,et al.  Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. , 1993, Journal of Biological Chemistry.

[47]  J. Exton,et al.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. , 1993, The Journal of biological chemistry.

[48]  A. Abadie,et al.  Intracellular signaling events associated with the induction of DNA synthesis in human B lymphocytes. II. Different pathways triggered by IL-2 and IL-4. , 1993, Cellular immunology.

[49]  T. Taniguchi,et al.  The interleukin-2 receptors: insights into a complex signalling mechanism. , 1992, Biochimica et biophysica acta.

[50]  P. Bryant,et al.  Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[52]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[53]  M. Waterfield,et al.  Phosphatidylinositol 3-kinase: a novel effector. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[54]  M. Diaz-Meco,et al.  Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes , 1992, Molecular and cellular biology.

[55]  C. Crews,et al.  Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Hawkins,et al.  Receptor specificity of growth factor-stimulated synthesis of 3-phosphorylated inositol lipids in Swiss 3T3 cells. , 1992, The Journal of biological chemistry.

[57]  E. Gelfand,et al.  Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells. , 1992, Biochemical and biophysical research communications.

[58]  J. Avruch,et al.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.

[59]  S. Volinia,et al.  Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit , 1992, Cell.

[60]  S. Schreiber Immunophilin-sensitive protein phosphatase action in cell signaling pathways , 1992, Cell.

[61]  S. Ferrari,et al.  Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Miesfeld,et al.  Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events , 1992, Molecular and cellular biology.

[63]  G. Crabtree,et al.  Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.

[64]  I. Grants,et al.  Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin. , 1992, Cellular immunology.

[65]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[66]  Takashi Uchiyama,et al.  Signal transduction by interleukin 2 in human T cells: Activation of tyrosine and ribosomal S6 kinases and cell‐cycle regulatory genes , 1992, Journal of cellular physiology.

[67]  H. Lane,et al.  Inhibition or down-regulation of protein kinase C attenuates late phase p70s6k activation induced by epidermal growth factor but not by platelet-derived growth factor or insulin. , 1992, The Journal of biological chemistry.

[68]  N. Ruderman,et al.  Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution. , 1992, The Journal of biological chemistry.

[69]  J. Avruch,et al.  An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. , 1992, The Journal of biological chemistry.

[70]  J. Woodgett,et al.  Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini , 1991, Molecular and cellular biology.

[71]  A. Harel-Bellan,et al.  c-fos transcriptional activation by IL-2 in mouse CTL-L2 cells is mediated through two distinct signal transduction pathways converging on the same enhancer element. , 1991, Journal of immunology.

[72]  I. Mérida,et al.  IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. , 1991, Journal of immunology.

[73]  R. Abraham,et al.  Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes , 1991, Molecular and cellular biology.

[74]  G. Crabtree,et al.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A , 1991, Nature.

[75]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[76]  L. Cantley,et al.  Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.

[77]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[78]  J. Blenis,et al.  Distinct mechanisms for the activation of the RSK kinases/MAP2 kinase/pp90rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[79]  L. Stephens,et al.  Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils , 1991, Nature.

[80]  R. Erikson,et al.  Structure, expression, and regulation of protein kinases involved in the phosphorylation of ribosomal protein S6. , 1991, The Journal of biological chemistry.

[81]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[82]  V. Fried,et al.  cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.

[83]  A. Ullrich,et al.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases , 1991, Cell.

[84]  J. Blenis,et al.  Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction , 1991, Molecular and cellular biology.

[85]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[86]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[87]  L A Herzenberg,et al.  Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[88]  S. Emr,et al.  Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae , 1990, Molecular and cellular biology.

[89]  J. Avruch,et al.  Molecular structure of a major insulin/mitogen-activated 70-kDa S6 protein kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Orrenius,et al.  Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. , 1990, Journal of immunology.

[91]  E. Gelfand,et al.  Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation. , 1990, Journal of immunology.

[92]  J. Blenis,et al.  Identification of Xenopus S6 protein kinase homologs (pp90rsk) in somatic cells: phosphorylation and activation during initiation of cell proliferation , 1990, Molecular and cellular biology.

[93]  N. Sigal,et al.  The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. , 1990, Journal of immunology.

[94]  Susan S. Taylor,et al.  cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. , 1990, Annual review of biochemistry.

[95]  T. Taniguchi,et al.  A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization , 1989, Cell.

[96]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[97]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[98]  D. Alcorta,et al.  Sequence and expression of chicken and mouse rsk: homologs of Xenopus laevis ribosomal S6 kinase , 1989, Molecular and cellular biology.

[99]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[100]  Anthony J. Sinskey,et al.  Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells , 1988, Cell.

[101]  G. Mills,et al.  Interleukin-2 induces proliferation of T lymphocyte mutants lacking protein kinase C , 1988, Cell.

[102]  K. Smith,et al.  cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[103]  P. Taylor,et al.  An inositol tetrakisphosphate-containing phospholipid in activated neutrophils , 1988, Nature.

[104]  G. Kammer The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. , 1988, Immunology today.

[105]  E. Krebs,et al.  Mitogen-activated S6 kinase is stimulated via protein kinase C-dependent and independent pathways in Swiss 3T3 cells. , 1987, The Journal of biological chemistry.

[106]  G. Mills,et al.  Interleukin 2 does not induce phosphatidylinositol hydrolysis in activated T cells. , 1986, Journal of immunology.

[107]  J. Blenis,et al.  Stimulation of ribosomal protein S6 kinase activity by pp60v-src or by serum: dissociation from phorbol ester-stimulated activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[108]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[109]  R. Roskoski [1] Assays of protein kinase , 1983 .

[110]  R. Roskoski Assays of protein kinase. , 1983, Methods in enzymology.

[111]  K. Terao,et al.  Preparation and some properties of active subunits from rat liver ribosomes. , 1970, Biochemical and biophysical research communications.